Simplify Asset Management Inc.
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 7, 2025), Simplify Asset Management Inc. reported 87 stock positions worth $1.7 billion. Its top holding was iShares Core S&P 500 ETF (IVV) at 41.9% of the portfolio, followed by iShares Core U.S. Aggregate (AGG, 18.7%) and Simplify Aggregate Bond ETF (AGGH, 6.5%). Compared with Q1 2025, it opened 15 new positions, sold out of 20, added to 16 and reduced 49. The biggest buy was iShares Core U.S. Aggregate (AGG, shares +2%) and the biggest sale an exit from SS SPDR S&P 500 ETF Trust-US (SPY).
- Most Recent 13F
- Q2 2026
- Location
- Las Vegas, NV
- CIK
- 0001846368
- Portfolio Value
- $1.7B (Q2 2025)
- SEC Filing
- 0001172661-25-002950 ↗ filed Aug 7, 2025
Holdings Value
Holdings 87 stocks · $1.7B
| IVV iShares Core S&P 500 ETF | 41.89% | 1,113,386 | $691.3M | Reduce -7.5% |
| AGG iShares Core U.S. Aggregate | 18.69% | 3,109,340 | $308.4M | Add +2.0% |
| AGGH Simplify Aggregate Bond ETF | 6.49% | 5,193,254 | $107.2M | No change |
| QIS Simplify Multi-Qis Alt ETF | 5.23% | 3,927,620 | $86.4M | Reduce -2.8% |
| SPUC Simplify US Equity Income Et | 5.18% | 1,913,678 | $85.6M | Reduce -18.0% |
| NMB Simplify National Muni BND | 4.11% | 2,714,076 | $67.8M | Reduce -13.1% |
| TYA Simplify Intermediate Term | 2.47% | 3,022,182 | $40.8M | Reduce -23.4% |
| SBAR Simplify Barrier Income ETF | 1.75% | 1,100,000 | $28.8M | New |
| XV Simplify Target 15 Distr ETF | 1.61% | 1,000,000 | $26.6M | New |
| PAGP Plains GP Holdings LP | 1.50% | 1,272,360 | $24.7M | No change |
| LLY Eli Lilly & Co. | 0.67% | 14,117 | $11.0M | Reduce -1.2% |
| AKRO Akero Therapeutics Inc. | 0.47% | 145,609 | $7.8M | No change |
| TSLA Tesla Inc. | 0.46% | 24,141 | $7.7M | Add +87.1% |
| HODL Vaneck Bitcoin ETF | 0.46% | 248,616 | $7.6M | Add +104.7% |
| FOXY Simplify Currency Strtgy ETF | 0.46% | 289,943 | $7.6M | Reduce -37.5% |
| PCT Purecycle Technologies Inc. | 0.43% | 519,017 | $7.1M | Add +1.8% |
| ADMA Adma Biologics Inc. | 0.42% | 381,139 | $6.9M | Add +10.9% |
| EYE National Vision Holdings Inc. | 0.39% | 281,211 | $6.5M | New |
| GILD Gilead Sciences Inc. | 0.36% | 52,890 | $5.9M | Add +148.6% |
| NBIX Neurocrine Biosciences Inc. | 0.35% | 46,497 | $5.8M | Add +129.3% |
| ARQT Arcutis Biotherapeutics Inc. | 0.35% | 409,432 | $5.7M | Reduce -38.0% |
| WGS Genedx Holdings Corp. | 0.32% | 56,700 | $5.2M | New |
| PM Philip Morris International | 0.31% | 28,051 | $5.1M | Add +51.8% |
| PHAT Phathom Pharmaceuticals Inc. | 0.30% | 521,935 | $5.0M | Reduce -23.5% |
| ISRG Intuitive Surgical Inc. | 0.29% | 8,699 | $4.7M | Reduce -28.8% |
| CAH Cardinal Health Inc. | 0.24% | 23,229 | $3.9M | Reduce -54.6% |
| DHR Danaher Corp. | 0.22% | 18,245 | $3.6M | Reduce -56.4% |
| FLR Fluor Corp. | 0.21% | 68,174 | $3.5M | New |
| ABBV Abbvie Inc. | 0.21% | 18,384 | $3.4M | Reduce -9.9% |
| CVS CVS Health Corp. | 0.20% | 46,966 | $3.2M | Add +415.8% |
| ABEO Abeona Therapeutics Inc. | 0.19% | 558,584 | $3.2M | Add +36.7% |
| PCRX Pacira Biosciences Inc. | 0.17% | 120,843 | $2.9M | Reduce -9.8% |
| ACHV Achieve Life Sciences Inc. | 0.16% | 1,184,512 | $2.7M | Add +443.7% |
| COR Cencora Inc. | 0.16% | 8,753 | $2.6M | New |
| RMD Resmed Inc. | 0.16% | 10,005 | $2.6M | Reduce -9.9% |
| LITL Simplify PPR Sndlr US SM Cap | 0.15% | 91,464 | $2.5M | New |
| AZN Astrazeneca PLC-Spons ADR | 0.14% | 32,451 | $2.3M | Reduce -9.8% |
| REGN Regeneron Pharmaceuticals | 0.12% | 3,697 | $1.9M | Add +34.0% |
| MIST Milestone Pharmaceuticals Inc. | 0.12% | 990,000 | $1.9M | Add +16.5% |
| GEHC GE Healthcare Technology | 0.11% | 24,776 | $1.8M | New |
| DXCM Dexcom Inc. | 0.11% | 20,650 | $1.8M | Add +9.8% |
| ALHC Alignment Healthcare Inc. | 0.10% | 120,321 | $1.7M | Reduce -9.8% |
| RITM Rithm Capital Corp. | 0.10% | 142,085 | $1.6M | Reduce -25.5% |
| INSM Insmed Inc. | 0.09% | 15,536 | $1.6M | Reduce -24.7% |
| JNJ Johnson & Johnson | 0.09% | 10,005 | $1.5M | Reduce -76.3% |
| TCRX Tscan Therapeutics Inc. | 0.09% | 1,046,916 | $1.5M | No change |
| DGX Quest Diagnostics Inc. | 0.09% | 8,161 | $1.5M | Reduce -60.5% |
| DCTH Delcath Systems Inc. | 0.09% | 106,629 | $1.5M | Reduce -8.9% |
| APLT Applied Therapeutics Inc. | 0.08% | 4,487,505 | $1.4M | No change |
| RVTY Revvity Inc. | 0.08% | 14,426 | $1.4M | Reduce -9.8% |
| GH Guardant Health Inc. | 0.08% | 26,631 | $1.4M | New |
| BHVN Biohaven Ltd. | 0.08% | 96,389 | $1.4M | New |
| NKTR Nektar Therapeutics | 0.08% | 51,998 | $1.3M | New |
| ABT Abbott Laboratories | 0.08% | 9,794 | $1.3M | Reduce -9.8% |
| ZVRA Zevra Therapeutics Inc. | 0.08% | 147,000 | $1.3M | Add +22.5% |
| UNH Unitedhealth Group Inc. | 0.08% | 4,051 | $1.3M | Reduce -69.8% |
| IQV Iqvia Holdings Inc. | 0.08% | 7,940 | $1.3M | New |
| NLY Annaly Capital Management Inc. | 0.07% | 62,900 | $1.2M | Reduce -40.2% |
| SNY Sanofi-ADR | 0.06% | 20,716 | $1.0M | Reduce -49.0% |
| TMO Thermo Fisher Scientific Inc. | 0.05% | 2,147 | $871K | Reduce -76.3% |
| BNTC Benitec Biopharma Inc. | 0.05% | 69,173 | $809K | Reduce -9.8% |
| ARGX Argenx SE - ADR | 0.05% | 1,467 | $809K | Reduce -9.4% |
| AGNC AGNC Investment Corp. | 0.05% | 86,000 | $790K | Reduce -73.3% |
| BSX Boston Scientific Corp. | 0.05% | 7,103 | $763K | New |
| EYPT Eyepoint Inc. | 0.05% | 79,472 | $748K | Reduce -9.8% |
| CIM Chimera Investment Corp. | 0.04% | 51,025 | $708K | Reduce -27.8% |
| EW Edwards Lifesciences Corp. | 0.04% | 8,830 | $691K | Reduce -9.9% |
| NXTI Simplify Next Intg C Idx ETF | 0.04% | 22,303 | $686K | Reduce -13.6% |
| LGND Ligand Pharmaceuticals | 0.04% | 5,970 | $679K | Reduce -9.8% |
| TWO Two Harbors Investment Corp. filed as TWO HBRS INVT CORP | 0.03% | 53,250 | $574K | Add +71.8% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.03% | 15,210 | $553K | Reduce -10.0% |
| CI The Cigna Group | 0.03% | 1,544 | $510K | Reduce -92.8% |
| FULC Fulcrum Therapeutics Inc. | 0.03% | 73,154 | $503K | Reduce -9.8% |
| VRTX Vertex Pharmaceuticals Inc. | 0.03% | 1,081 | $481K | Reduce -9.5% |
| ATHIRA PHARMA INC | 0.03% | 1,492,792 | $451K | No change |
| COO The Cooper Cos Inc. | 0.03% | 6,224 | $443K | Reduce -9.9% |
| SYK Stryker Corp. | 0.03% | 1,098 | $434K | Reduce -9.4% |
| LIVN Livanova PLC | 0.02% | 8,905 | $401K | Reduce -5.7% |
| CAPR Capricor Therapeutics Inc. | 0.02% | 40,000 | $397K | New |
| TGTX TG Therapeutics Inc. | 0.02% | 10,204 | $367K | Reduce -9.6% |
| PODD Insulet Corp. | 0.02% | 1,006 | $316K | New |
| CHWY Chewy Inc. Class A | 0.02% | 6,451 | $275K | Reduce -9.0% |
| CYPH Cypherpunk Technologies Inc. filed as LEAP THERAPEUTICS INC | 0.02% | 857,360 | $255K | Reduce -9.8% |
| MMM 3M Co. | 0.01% | 1,606 | $244K | Reduce -9.3% |
| SNDX Syndax Pharmaceuticals Inc. | 0.01% | 25,049 | $235K | Reduce -83.0% |
| AGL Agilon Health Inc. | 0.01% | 100,152 | $230K | Reduce -9.8% |
| QVCAQ QVC Group Inc. | 0.00% | 12,000 | $33K | No change |
Options reported separately and not counted above: GLD puts ($306.8M), IBIT calls ($30.5M).
Portfolio Sells Q1 2025 → Q2 2025
| SPY SS SPDR S&P 500 ETF Trust-US | Sold out | 0.00% | −22.77 |
| CDX Simplify High Yield ETF | Sold out | 0.00% | −1.39 |
| CI The Cigna Group | Reduce -92.8% | 0.03% | −0.30 |
| MDGL Madrigal Pharmaceuticals Inc. | Sold out | 0.00% | −0.25 |
| UNH Unitedhealth Group Inc. | Reduce -69.8% | 0.08% | −0.25 |
| JNJ Johnson & Johnson | Reduce -76.3% | 0.09% | −0.23 |
| DHR Danaher Corp. | Reduce -56.4% | 0.22% | −0.18 |
| RNAM Avidity Biosciences Inc. | Sold out | 0.00% | −0.17 |
| TMO Thermo Fisher Scientific Inc. | Reduce -76.3% | 0.05% | −0.16 |
| ARQT Arcutis Biotherapeutics Inc. | Reduce -38.0% | 0.35% | −0.13 |
| FOXY Simplify Currency Strtgy ETF | Reduce -37.5% | 0.46% | −0.13 |
| IJR iShares Core S&P Small-Cap E | Sold out | 0.00% | −0.11 |
| TSLL Dirx DLY Tsla Bul 2X ETF-Aui | Sold out | 0.00% | −0.11 |
| HARD Simplify Commodities STR K-1 | Sold out | 0.00% | −0.10 |
| AGNC AGNC Investment Corp. | Reduce -73.3% | 0.05% | −0.10 |
| RFIX Simplify Bond Bull ETF | Sold out | 0.00% | −0.09 |
| CTA Simplify Managed Futures St | Sold out | 0.00% | −0.09 |
| CAH Cardinal Health Inc. | Reduce -54.6% | 0.24% | −0.09 |
| SCY Simplify US Smllcap Plus Inc. | Sold out | 0.00% | −0.09 |
| TFX Teleflex Inc. | Sold out | 0.00% | −0.08 |
| DGX Quest Diagnostics Inc. | Reduce -60.5% | 0.09% | −0.07 |
| SNDX Syndax Pharmaceuticals Inc. | Reduce -83.0% | 0.01% | −0.07 |
| WUSA Simplify Wo US Eq 150/50 ETF | Sold out | 0.00% | −0.06 |
| PMT Pennymac Mortgage Investment | Sold out | 0.00% | −0.06 |
| SNY Sanofi-ADR | Reduce -49.0% | 0.06% | −0.04 |
| SPQ Simplify US Equity Plus Qis | Sold out | 0.00% | −0.04 |
| ESTA Establishment Labs Holdings | Sold out | 0.00% | −0.03 |
| NXTV Simplify Next Int Va Idx ETF | Sold out | 0.00% | −0.03 |
| ARR Armour Residential REIT Inc. | Sold out | 0.00% | −0.03 |
| NLY Annaly Capital Management Inc. | Reduce -40.2% | 0.07% | −0.03 |
| ALHC Alignment Healthcare Inc. | Reduce -9.8% | 0.10% | −0.01 |
| ZBH Zimmer Biomet Holdings Inc. | Sold out | 0.00% | −0.01 |
| SRPT Sarepta Therapeutics Inc. | Sold out | 0.00% | −0.01 |
| CMPX Compass Therapeutics Inc. | Sold out | 0.00% | −0.01 |
| AGL Agilon Health Inc. | Reduce -9.8% | 0.01% | −0.01 |
| RITM Rithm Capital Corp. | Reduce -25.5% | 0.10% | −0.00 |
| COO The Cooper Cos Inc. | Reduce -9.9% | 0.03% | −0.00 |
| CIM Chimera Investment Corp. | Reduce -27.8% | 0.04% | +0.00 |
| TGTX TG Therapeutics Inc. | Reduce -9.6% | 0.02% | +0.00 |
| CYPH Cypherpunk Technologies Inc. | Reduce -9.8% | 0.02% | +0.00 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -9.5% | 0.03% | +0.00 |
| BNTC Benitec Biopharma Inc. | Reduce -9.8% | 0.05% | +0.00 |
| MMM 3M Co. | Reduce -9.3% | 0.01% | +0.00 |
| ISRG Intuitive Surgical Inc. | Reduce -28.8% | 0.29% | +0.00 |
| ARGX Argenx SE - ADR | Reduce -9.4% | 0.05% | +0.00 |
| RARE Ultragenyx Pharmaceutical Inc. | Reduce -10.0% | 0.03% | +0.00 |
| SYK Stryker Corp. | Reduce -9.4% | 0.03% | +0.01 |
| RVTY Revvity Inc. | Reduce -9.8% | 0.08% | +0.01 |
| CHWY Chewy Inc. Class A | Reduce -9.0% | 0.02% | +0.01 |
| LIVN Livanova PLC | Reduce -5.7% | 0.02% | +0.01 |
Portfolio Buys Q1 2025 → Q2 2025
| AGG iShares Core U.S. Aggregate | Add +2.0% | 18.69% | +4.62 |
| SBAR Simplify Barrier Income ETF | New | 1.75% | +1.75 |
| XV Simplify Target 15 Distr ETF | New | 1.61% | +1.61 |
| EYE National Vision Holdings Inc. | New | 0.39% | +0.39 |
| HODL Vaneck Bitcoin ETF | Add +104.7% | 0.46% | +0.33 |
| WGS Genedx Holdings Corp. | New | 0.32% | +0.32 |
| TSLA Tesla Inc. | Add +87.1% | 0.46% | +0.31 |
| PCT Purecycle Technologies Inc. | Add +1.8% | 0.43% | +0.27 |
| NBIX Neurocrine Biosciences Inc. | Add +129.3% | 0.35% | +0.25 |
| GILD Gilead Sciences Inc. | Add +148.6% | 0.36% | +0.24 |
| FLR Fluor Corp. | New | 0.21% | +0.21 |
| PM Philip Morris International | Add +51.8% | 0.31% | +0.17 |
| CVS CVS Health Corp. | Add +415.8% | 0.20% | +0.17 |
| COR Cencora Inc. | New | 0.16% | +0.16 |
| LITL Simplify PPR Sndlr US SM Cap | New | 0.15% | +0.15 |
| ACHV Achieve Life Sciences Inc. | Add +443.7% | 0.16% | +0.14 |
| GEHC GE Healthcare Technology | New | 0.11% | +0.11 |
| ADMA Adma Biologics Inc. | Add +10.9% | 0.42% | +0.10 |
| ABEO Abeona Therapeutics Inc. | Add +36.7% | 0.19% | +0.10 |
| MIST Milestone Pharmaceuticals Inc. | Add +16.5% | 0.12% | +0.08 |
| GH Guardant Health Inc. | New | 0.08% | +0.08 |
| BHVN Biohaven Ltd. | New | 0.08% | +0.08 |
| NKTR Nektar Therapeutics | New | 0.08% | +0.08 |
| IQV Iqvia Holdings Inc. | New | 0.08% | +0.08 |
| DXCM Dexcom Inc. | Add +9.8% | 0.11% | +0.05 |
| BSX Boston Scientific Corp. | New | 0.05% | +0.05 |
| ZVRA Zevra Therapeutics Inc. | Add +22.5% | 0.08% | +0.04 |
| REGN Regeneron Pharmaceuticals | Add +34.0% | 0.12% | +0.04 |
| CAPR Capricor Therapeutics Inc. | New | 0.02% | +0.02 |
| PODD Insulet Corp. | New | 0.02% | +0.02 |
| TWO Two Harbors Investment Corp. | Add +71.8% | 0.03% | +0.02 |
Options Activity Q1 2025 → Q2 2025
| GLD SPDR Gold Shares | put | Reduce -29.8% | 997,500 | $306.8M |
| MSTR Strategy Inc. | put | Sold out | 391,500 | $118.8Mbefore exit |
| IBIT iShares Bitcoin Trust ETF | call | New | 510,000 | $30.5M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 136 | $7.1B | SBIL, IVV, AGG, TUA, SPUC |
| Q1 2026 | 142 | $6.5B | SBIL, IVV, AGG, TUA, SPUC |
| Q4 2025 | 140 | $6.1B | SBIL, IVV, AGG, SPUC, QIS |
| Q3 2025 | 127 | $4.9B | SBIL, IVV, AGG, QIS, SPUC |
| Q2 2025 | 87 | $1.7B | IVV, AGG, AGGH, QIS, SPUC |
| Q1 2025 | 92 | $2.1B | IVV, SPY, AGG, AGGH, QIS |
| Q4 2024 | 89 | $1.4B | IVV, AGG, BUCK, AGGH, NMB |
| Q3 2024Amended | 101 | $1.5B | IVV, AGG, AGGH, BUCK, NMB |
| Q2 2024 | 100 | $1.1B | IVV, AGG, AGGH, CDX, BUCK |
| Q1 2024 | 96 | $1.0B | IVV, AGGH, BUCK, AGG, PAGP |